Journey Medical Corporation
DERM
$5.01
$0.010.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.07M | 17.03M | 15.01M | 13.14M | 12.62M |
| Total Other Revenue | 13.00K | 606.00K | -- | -- | 1.00M |
| Total Revenue | 16.08M | 17.63M | 15.01M | 13.14M | 13.62M |
| Cost of Revenue | 5.44M | 5.76M | 4.94M | 4.79M | 4.68M |
| Gross Profit | 10.64M | 11.88M | 10.07M | 8.35M | 8.94M |
| SG&A Expenses | 9.86M | 12.05M | 11.88M | 10.57M | 10.06M |
| Depreciation & Amortization | 1.07M | 1.06M | 1.06M | 1.07M | 981.00K |
| Other Operating Expenses | -- | -- | -- | -- | -4.55M |
| Total Operating Expenses | 16.52M | 19.16M | 17.89M | 16.46M | 11.39M |
| Operating Income | -443.00K | -1.53M | -2.88M | -3.32M | 2.23M |
| Income Before Tax | -1.25M | -2.32M | -3.74M | -4.07M | 1.58M |
| Income Tax Expenses | 0.00 | -- | 60.00K | -- | 61.00K |
| Earnings from Continuing Operations | -1.25M | -2.32M | -3.80M | -4.07M | 1.52M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.25M | -2.32M | -3.80M | -4.07M | 1.52M |
| EBIT | -443.00K | -1.53M | -2.88M | -3.32M | 2.23M |
| EBITDA | 622.00K | -465.00K | -1.81M | -2.26M | 3.22M |
| EPS Basic | -0.05 | -0.09 | -0.16 | -0.18 | 0.07 |
| Normalized Basic EPS | -0.03 | -0.06 | -0.10 | -0.11 | 0.05 |
| EPS Diluted | -0.05 | -0.09 | -0.16 | -0.18 | 0.07 |
| Normalized Diluted EPS | -0.03 | -0.06 | -0.10 | -0.11 | 0.05 |
| Average Basic Shares Outstanding | 27.11M | 24.96M | 23.29M | 22.61M | 21.31M |
| Average Diluted Shares Outstanding | 27.11M | 24.96M | 23.29M | 22.61M | 21.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |